Navigation Links
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
Date:10/26/2011

nd effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The Company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future ev
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
2. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
3. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
6. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
7. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
8. Bionovo Announces 2010 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
10. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... FAIRFAX, Va. , Aug. 27, 2014 ... in the legs due to buildup of fatty plaque ... expected in the aging patient population and in incidences ... Radiology offers its Lower Extremity Arterial RevascularizatioN ... Ariz. Endovascular specialists and interested residents and ...
(Date:8/27/2014)... Research and Markets  has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
... 6, 2011 Agendia, an innovative molecular diagnostics ... paraffin embedded tissue technology applied to their Symphony™ ... in a paraffin embedded tissue format offers their ... development and validation found in Agendia,s breast cancer ...
... 6, 2011  TRACE released the 2011 BRIBEline United ... demands for bribes reported in specific countries.  Previous reports ... Ukraine, Russia, India and China. "The ... contribution to the prevention of bribery," said TRACE Founder ...
Cached Medicine Technology:Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue 2TRACE Releases Report on Bribe Demands in the United States 2TRACE Releases Report on Bribe Demands in the United States 3
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Latinos ... 5th, 6th and 7th at the Florida State Fair ... celebrates all Latino art and cultures from around the ... their platinum sponsor Go Smart Mobile and Univision Mobile, ... Festival is expecting an estimate of 4,000 people from ...
(Date:8/27/2014)... 27, 2014 New Jersey’s own Morgan ... Ridgewood County Club during The Barclays – and thanks ... of the tournament’s four rounds, stepped his way into ... Cross Blue Shield of New Jersey (Horizon BCBNSNJ) Walking ... Wyckoff native playing before family and friends at the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Seventy-three members ... Pharmacy (SoP) celebrated the beginning of their careers as ... Saturday, August 23. Students entering a four-year PharmD program ... care ?to welcome them into the profession as colleagues ... ceremony held at the Garrison Theater in Claremont, Calif., ...
(Date:8/27/2014)... therapy has spawned a prevalent but preventable side effect: ... according to a study by a Yale School of ... published in the Aug. 27 online issue of the ... to severe hot flashes also called vasomotor symptoms ... with VMS experience more than feeling hot; other frequently ...
(Date:8/27/2014)... Dennis Thompson HealthDay Reporter ... who has been mugged in a dark alley will likely ... a fear of being attacked. But neuroscientists working with ... memories are linked with positive and negative emotions. And in ... attached to a memory. In essence, they made once-reluctant ...
Breaking Medicine News(10 mins):Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:The high cost of hot flashes: Millions in lost wages preventable 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3
... FRIDAY, March 4 (HealthDay News) -- A diet rich in foods ... stroke by 21 percent and may also lower your risk of ... include bananas and other fruits and vegetables, as well as fish, ... sweet potato and tomato paste top the list, according to the ...
... designed to assist weight loss by limiting the amount of ... It has been used for several years to treat obesity ... Clinical Obesity reveals that bariatric surgery can result in ... Aikenhead of the International Association for the Study of Obesity ...
... News)-- Men need more support before and after their child ... they were happy to attend childbirth classes for their partner,s ... and did not have a ready outlet for their own ... for a University of Gothenburg thesis by midwife Asa Premberg ...
... ALS or more popularly, Lou Gehrig,s disease, is a ... brain and spinal cord neurons, resulting in the gradual ... In a new paper, published in the ... Nature Neuroscience , a team of scientists at the ...
... , FRIDAY, March 4 (HealthDay News) -- Poor ... of people worldwide at risk for early death, a ... treatment and management in Colombia, England, Iran, Mexico, Scotland, ... of U.S. adult diabetics -- more than 16 million ...
... Professor of Molecular & Cell Biology at Boston University ... of Microbiology at Boston University School of Medicine discovered ... of gene expression. The study describing this work titled, ... Premature Transcription Termination," appears in the March 4 issue ...
Cached Medicine News:Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 2Health News:Potassium-Rich Foods May Cut Stroke, Heart Disease Risk 3Health News:Study Finds Men Need More Support Before, After Child Birth 2Health News:Loss of key protein boosts neuron loss in ALS 2Health News:Diabetes Often Not Diagnosed or Treated Properly 2Health News:Novel mechanism for control of gene expression revealed 2
Open wire style 16 mm blade with a wing tip twist giving the surgeon better on-axis accessibility....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: